iCAD (ICAD) - Cash Funds Calculated per Share

Symbol and logo of brand iCAD (ICAD)

iCAD, Inc. is implementing ProFound AI platforms for the early diagnosis of breast cancer. The cash per share structure visualizes this expansion, with the parameter mark equal to 0.74. The cloud-based SaaS model ensures seamless scaling of services without capital expenditures. Simultaneously, the developer is optimizing clinic energy consumption, adhering to environmental standards during the creation of tomography systems.

icadmed.com - ICAD Cash per Share (period 07/04/2022 - 08/02/2025)

Comprehensive metric breakdowns and analytics for iCAD (ICAD)

- cash and cash flow data:
Summary company analysis:ICAD iCAD
Manufactured product of icadmed.com

This indicator measures the actual volume of free capital per share on a daily basis, eliminating the inaccuracies associated with quarterly reporting. For iCAD, Inc. (ICAD), this is a critical resource that enables the scaling of SaaS platforms and expansion into radiology clinics. Analyzing the current cash per share level confirms the real liquidity trend. While an increase in this metric strengthens business resilience, excessive accumulation may reduce the overall return on assets. Investors should utilize this metric to distinguish fundamental growth from speculation.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com